Navigation Links
PCMA Statement on Passage of Medicare Bill: E-Prescribing Requirement a Major Victory for Seniors
Date:7/9/2008

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) released the following statement on Senate passage of the Medicare bill, which includes a provision that requires physicians to use electronic prescribing (e-prescribing) in Medicare:

"The inclusion of an e-prescribing requirement in Medicare is a major victory for America's seniors. From a patient's perspective, e-prescribing is the most important issue in the Medicare bill because it saves lives and saves money. This is a historic step forward for e-prescribing as the new requirement in Medicare will now lead to broader adoption of overall health care information technology.

"We are also pleased that both the effective date of the AMP payment cut as well as the date for publication of AMP data have been delayed until September 2009.

"However, PCMA continues to oppose other special interest provisions which would pay independent pharmacists twice as fast as all other Medicare providers. This will increase costs and provide no added benefit for seniors."

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pelosi Statement on Senate Vote on Medicare Improvements Act
2. Statement of the Leapfrog Group on Hospital Overdose of Up to 17 Babies at CHRISTUS Spohn
3. AHIP Statement on New CBO Report Showing That Senate Legislation Will Cut Medicare Advantage Enrollment by 2.3 Million
4. American Legacy Foundation(R) Statement of Support for the Federal Trade Commission Reversal on Tar and Nicotine Yield Statements on Cigarettes
5. The ECNP consensus statement on bipolar depression
6. Blue Cross and Blue Shield Association Statement: Health Care America Now
7. Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care
8. Statement Regarding the Filing of Signatures to Put the Human Embryo Stem Cell Issue on the November Statewide Ballot
9. GO3 Statement Regarding Erroneous Coverage in Star Magazine
10. AAHSA Statement: Therapy Caps Ration Care
11. Statement by Christine James-Brown, President and CEO, Child Welfare League of America (CWLA) Re: Moratorium on Medicaid Regulations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: